Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 704

1.

Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors.

Malbari F, Staggers KA, Minard CG, Weiner HL, Chintagumpala MM, Levy AS.

J Neurooncol. 2020 Feb 5. doi: 10.1007/s11060-020-03416-9. [Epub ahead of print]

PMID:
32026434
2.

Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosis.

Glanz BI, Zurawski J, Gonzalez CT, Shamah R, Ratajska A, Chitnis T, Weiner HL, Healy BC.

Mult Scler Relat Disord. 2020 Jan 11;40:101944. doi: 10.1016/j.msard.2020.101944. [Epub ahead of print]

PMID:
32007653
3.

Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study.

Bakshi R, Healy BC, Dupuy SL, Kirkish G, Khalid F, Gundel T, Asteggiano C, Yousuf F, Alexander A, Hauser SL, Weiner HL, Henry RG; SUMMIT consortium.

J Neuroimaging. 2020 Jan 29. doi: 10.1111/jon.12688. [Epub ahead of print]

PMID:
31994814
4.

Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosis.

Chitnis T, Glanz BI, Gonzalez C, Healy BC, Saraceno TJ, Sattarnezhad N, Diaz-Cruz C, Polgar-Turcsanyi M, Tummala S, Bakshi R, Bajaj VS, Ben-Shimol D, Bikhchandani N, Blocker AW, Burkart J, Cendrillon R, Cusack MP, Demiralp E, Jooste SK, Kharbouch A, Lee AA, Lehár J, Liu M, Mahadevan S, Murphy M, Norton LC, Parlikar TA, Pathak A, Shoeb A, Soderberg E, Stephens P, Stoertz AH, Thng F, Tumkur K, Wang H, Rhodes J, Rudick RA, Ransohoff RM, Phillips GA, Bruzik E, Marks WJ, Weiner HL, Snyder TM.

NPJ Digit Med. 2019 Dec 11;2:123. doi: 10.1038/s41746-019-0197-7. eCollection 2019.

5.

Calorie restriction slows age-related microbiota changes in an Alzheimer's disease model in female mice.

Cox LM, Schafer MJ, Sohn J, Vincentini J, Weiner HL, Ginsberg SD, Blaser MJ.

Sci Rep. 2019 Nov 29;9(1):17904. doi: 10.1038/s41598-019-54187-x.

6.

Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila.

Liu S, Rezende RM, Moreira TG, Tankou SK, Cox LM, Wu M, Song A, Dhang FH, Wei Z, Costamagna G, Weiner HL.

Cell Host Microbe. 2019 Dec 11;26(6):779-794.e8. doi: 10.1016/j.chom.2019.10.008. Epub 2019 Nov 26.

PMID:
31784260
7.

Giant Symptomatic Meningocele as a Delayed, Adult Complication of Lipomyelomeningocele.

North RY, Verla T, Bartlett E, Reece E, Weiner HL, Ropper AE.

World Neurosurg. 2020 Feb;134:532-535. doi: 10.1016/j.wneu.2019.11.086. Epub 2019 Nov 21.

PMID:
31760189
8.

An argument for broad use of high efficacy treatments in early multiple sclerosis.

Stankiewicz JM, Weiner HL.

Neurol Neuroimmunol Neuroinflamm. 2019 Nov 22;7(1). pii: e636. doi: 10.1212/NXI.0000000000000636. Print 2020 Jan. Review.

9.

7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.

Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, Bakshi R.

Mult Scler. 2020 Feb;26(2):177-187. doi: 10.1177/1352458519885106. Epub 2019 Nov 12.

PMID:
31714181
10.

History of fatigue in multiple sclerosis is associated with grey matter atrophy.

Palotai M, Nazeri A, Cavallari M, Healy BC, Glanz B, Gold SM, Weiner HL, Chitnis T, Guttmann CRG.

Sci Rep. 2019 Oct 14;9(1):14781. doi: 10.1038/s41598-019-51110-2.

11.

γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance.

Rezende RM, Nakagaki BN, Moreira TG, Lopes JR, Kuhn C, Tatematsu BK, Boulenouar S, Maghzi AH, Rubino S, Menezes GB, Chitnis T, Weiner HL.

J Immunol. 2019 Nov 15;203(10):2621-2629. doi: 10.4049/jimmunol.1900784. Epub 2019 Oct 2.

PMID:
31578268
12.

Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity.

Garo LP, Ajay AK, Fujiwara M, Beynon V, Kuhn C, Gabriely G, Sadhukan S, Raheja R, Rubino S, Weiner HL, Murugaiyan G.

Cell Rep. 2019 Sep 24;28(13):3353-3366.e5. doi: 10.1016/j.celrep.2019.07.065.

13.

Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors.

Gonzalez CG, Tankou SK, Cox LM, Casavant EP, Weiner HL, Elias JE.

Sci Rep. 2019 Aug 28;9(1):12460. doi: 10.1038/s41598-019-48495-5.

14.

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy.

Rezende RM, Lopes ME, Menezes GB, Weiner HL.

J Vis Exp. 2019 Aug 9;(150). doi: 10.3791/59335.

PMID:
31449231
15.

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis.

Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB.

Crohns Colitis 360. 2019 Jul;1(2):otz009. doi: 10.1093/crocol/otz009. Epub 2019 Jun 7.

16.

The sex-specific interaction of the microbiome in neurodegenerative diseases.

Cox LM, Abou-El-Hassan H, Maghzi AH, Vincentini J, Weiner HL.

Brain Res. 2019 Dec 1;1724:146385. doi: 10.1016/j.brainres.2019.146385. Epub 2019 Aug 13. Review.

PMID:
31419428
17.

Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depression.

Palotai M, Cavallari M, Koubiyr I, Morales Pinzon A, Nazeri A, Healy BC, Glanz B, Weiner HL, Chitnis T, Guttmann CR.

Mult Scler. 2019 Aug 16:1352458519869185. doi: 10.1177/1352458519869185. [Epub ahead of print]

PMID:
31418637
18.

Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes.

Yano H, Gonzalez C, Healy BC, Glanz BI, Weiner HL, Chitnis T.

Mult Scler Relat Disord. 2019 Oct;35:119-127. doi: 10.1016/j.msard.2019.07.021. Epub 2019 Jul 25.

PMID:
31374460
19.

Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.

Singhal T, O'Connor K, Dubey S, Pan H, Chu R, Hurwitz S, Cicero S, Tauhid S, Silbersweig D, Stern E, Kijewski M, DiCarli M, Weiner HL, Bakshi R.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5):e587. doi: 10.1212/NXI.0000000000000587. eCollection 2019 Sep.

20.

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.

Peroni S, Sorosina M, Malhotra S, Clarelli F, Osiceanu AM, Ferrè L, Roostaei T, Rio J, Midaglia L, Villar LM, Álvarez-Cermeño JC, Guaschino C, Radaelli M, Citterio L, Lechner-Scott J, Spataro N, Navarro A, Martinelli V, Montalban X, Weiner HL, de Jager P, Comi G, Esposito F, Comabella M, Martinelli-Boneschi F.

Mult Scler. 2019 Jun 21:1352458519851428. doi: 10.1177/1352458519851428. [Epub ahead of print]

PMID:
31221001
21.

The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.

Zurawski J, Glanz BI, Healy BC, Tauhid S, Khalid F, Chitnis T, Weiner HL, Bakshi R.

J Neurol Sci. 2019 Aug 15;403:38-43. doi: 10.1016/j.jns.2019.04.023. Epub 2019 Apr 18.

22.

Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.

Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutiérrez-Vázquez C, Kenison J, Tjon EC, Barroso A, Vandeventer T, de Lima KA, Rothweiler S, Mayo L, Ghannam S, Zandee S, Healy L, Sherr D, Farez MF, Prat A, Antel J, Reardon DA, Zhang H, Robson SC, Getz G, Weiner HL, Quintana FJ.

Nat Neurosci. 2019 Sep;22(9):1533. doi: 10.1038/s41593-019-0446-8.

PMID:
31197266
23.

Beta-Catenin Mutation with Complex Chromosomal Changes in Desmoid Tumor of the Scalp: A Case Report.

Liu G, Weiner HL, Pederson WC, Davies L, Buchanan EP.

Craniomaxillofac Trauma Reconstr. 2019 Jun;12(2):146-149. doi: 10.1055/s-0038-1676078. Epub 2018 Nov 16.

PMID:
31073365
24.

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.

Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutiérrez-Vázquez C, Kenison J, Tjon EC, Barroso A, Vandeventer T, de Lima KA, Rothweiler S, Mayo L, Ghannam S, Zandee S, Healy L, Sherr D, Farez MF, Prat A, Antel J, Reardon DA, Zhang H, Robson SC, Getz G, Weiner HL, Quintana FJ.

Nat Neurosci. 2019 May;22(5):729-740. doi: 10.1038/s41593-019-0370-y. Epub 2019 Apr 8. Erratum in: Nat Neurosci. 2019 Sep;22(9):1533.

PMID:
30962630
25.

The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research.

Das S; Extracellular RNA Communication Consortium, Ansel KM, Bitzer M, Breakefield XO, Charest A, Galas DJ, Gerstein MB, Gupta M, Milosavljevic A, McManus MT, Patel T, Raffai RL, Rozowsky J, Roth ME, Saugstad JA, Van Keuren-Jensen K, Weaver AM, Laurent LC.

Cell. 2019 Apr 4;177(2):231-242. doi: 10.1016/j.cell.2019.03.023. Review.

PMID:
30951667
26.

Pediatric Craniomaxillofacial Oncologic Reconstruction.

Dempsey RF, Chelius DC Jr, Pederson WC, Maricevich M, Dimachkieh AL, Kupferman ME, Weiner HL, Hollier LH Jr, Buchanan EP.

Clin Plast Surg. 2019 Apr;46(2):261-273. doi: 10.1016/j.cps.2018.11.011. Epub 2019 Jan 30. Review.

PMID:
30851757
27.

MRI phenotypes in MS: Longitudinal changes and miRNA signatures.

Hemond CC, Healy BC, Tauhid S, Mazzola MA, Quintana FJ, Gandhi R, Weiner HL, Bakshi R.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 14;6(2):e530. doi: 10.1212/NXI.0000000000000530. eCollection 2019 Mar.

28.

Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.

Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, Häring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J.

Ann Clin Transl Neurol. 2018 Oct 16;5(12):1478-1491. doi: 10.1002/acn3.638. eCollection 2018 Dec.

29.

Food allergies are associated with increased disease activity in multiple sclerosis.

Fakih R, Diaz-Cruz C, Chua AS, Gonzalez C, Healy BC, Sattarnezhad N, Glanz BI, Weiner HL, Chitnis T.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):629-635. doi: 10.1136/jnnp-2018-319301. Epub 2018 Dec 18.

PMID:
30563943
30.

Publisher Correction: An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells.

Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F.

Nat Immunol. 2019 Jan;20(1):109. doi: 10.1038/s41590-018-0264-2.

PMID:
30448856
31.

Acute microglia ablation induces neurodegeneration in the somatosensory system.

Rubino SJ, Mayo L, Wimmer I, Siedler V, Brunner F, Hametner S, Madi A, Lanser A, Moreira T, Donnelly D, Cox L, Rezende RM, Butovsky O, Lassmann H, Weiner HL.

Nat Commun. 2018 Nov 1;9(1):4578. doi: 10.1038/s41467-018-05929-4.

32.

Invasive monitoring after resection of epileptogenic neocortical lesions in multistaged epilepsy surgery in children.

Hidalgo ET, Frankel HG, Rodriguez C, Orillac C, Phillips S, Patel N, Devinsky O, Friedman D, Weiner HL.

Epilepsy Res. 2018 Dec;148:48-54. doi: 10.1016/j.eplepsyres.2018.09.001. Epub 2018 Sep 19.

PMID:
30384114
33.

Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis.

Healy BC, Zurawski J, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI.

Mult Scler. 2019 Nov;25(13):1791-1799. doi: 10.1177/1352458518810159. Epub 2018 Nov 1.

PMID:
30381985
34.

Epilepsy surgery in Panama: Establishment of a successful hybrid program as a model for small middle-income countries.

Kuzniecky R, Baez C, Aranda G, Hidalgo ET, Grover A, Orillac C, Zelenka Y, Weiner HL.

Epilepsia. 2018 Nov;59(11):2137-2144. doi: 10.1111/epi.14571. Epub 2018 Oct 19.

35.

Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study.

Wray S, Havrdova E, Snydman DR, Arnold DL, Cohen JA, Coles AJ, Hartung HP, Selmaj KW, Weiner HL, Daizadeh N, Margolin DH, Chirieac MC, Compston DAS.

Mult Scler. 2019 Oct;25(12):1605-1617. doi: 10.1177/1352458518796675. Epub 2018 Oct 5.

36.

CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells.

Moreira TG, Horta LS, Gomes-Santos AC, Oliveira RP, Queiroz NMGP, Mangani D, Daniel B, Vieira AT, Liu S, Rodrigues AM, Gomes DA, Gabriely G, Ferreira E, Weiner HL, Rezende RM, Nagy L, Faria AMC.

Mucosal Immunol. 2019 Jan;12(1):188-199. doi: 10.1038/s41385-018-0090-8. Epub 2018 Oct 2.

PMID:
30279515
37.

Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate.

Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL.

J Neurol Sci. 2018 Nov 15;394:127-131. doi: 10.1016/j.jns.2018.09.020. Epub 2018 Sep 17.

PMID:
30248571
38.

Central nervous system manifestations of tuberous sclerosis complex.

Lu DS, Karas PJ, Krueger DA, Weiner HL.

Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):291-298. doi: 10.1002/ajmg.c.31647. Epub 2018 Sep 19. Review.

PMID:
30230171
39.

Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis.

Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, Tauhid S.

eNeurologicalSci. 2018 Jul 4;12:42-46. doi: 10.1016/j.ensci.2018.07.002. eCollection 2018 Sep.

40.

Microglial signatures and their role in health and disease.

Butovsky O, Weiner HL.

Nat Rev Neurosci. 2018 Oct;19(10):622-635. doi: 10.1038/s41583-018-0057-5. Review.

PMID:
30206328
41.

An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells.

Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F.

Nat Immunol. 2018 Oct;19(10):1126-1136. doi: 10.1038/s41590-018-0200-5. Epub 2018 Sep 10. Erratum in: Nat Immunol. 2019 Jan;20(1):109.

42.

Identification of MS-specific serum miRNAs in an international multicenter study.

Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(5):e491. doi: 10.1212/NXI.0000000000000491. eCollection 2018 Sep.

43.

γδ T cells control humoral immune response by inducing T follicular helper cell differentiation.

Rezende RM, Lanser AJ, Rubino S, Kuhn C, Skillin N, Moreira TG, Liu S, Gabriely G, David BA, Menezes GB, Weiner HL.

Nat Commun. 2018 Aug 8;9(1):3151. doi: 10.1038/s41467-018-05487-9.

44.

18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.

Singhal T, OʼConnor K, Dubey S, Belanger AP, Hurwitz S, Chu R, Tauhid S, Kijewski MF, DiCarli MF, Weiner HL, Bakshi R.

Clin Nucl Med. 2018 Sep;43(9):e289-e295. doi: 10.1097/RLU.0000000000002179.

PMID:
30004939
45.

Cellular Components and Mechanisms of Oral Tolerance Induction.

Rezende RM, Weiner HL.

Crit Rev Immunol. 2018;38(3):207-231. doi: 10.1615/CritRevImmunol.2018026181. Review.

PMID:
30004858
46.

Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachment.

Okunuki Y, Mukai R, Pearsall EA, Klokman G, Husain D, Park DH, Korobkina E, Weiner HL, Butovsky O, Ksander BR, Miller JW, Connor KM.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6264-E6273. doi: 10.1073/pnas.1719601115. Epub 2018 Jun 18.

47.

A probiotic modulates the microbiome and immunity in multiple sclerosis.

Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisäkk P, Pierre IV, Hrishikesh L, Gandhi R, Cook S, Glanz B, Stankiewicz J, Weiner HL.

Ann Neurol. 2018 Jun;83(6):1147-1161. doi: 10.1002/ana.25244. Epub 2018 Jun 8.

48.

Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples.

Wimmer I, Tröscher AR, Brunner F, Rubino SJ, Bien CG, Weiner HL, Lassmann H, Bauer J.

Sci Rep. 2018 Apr 20;8(1):6351. doi: 10.1038/s41598-018-24781-6.

49.

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, Wolinsky JS.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):346-356. doi: 10.1002/acn3.534. eCollection 2018 Mar.

50.

Multiple Sclerosis: Mechanisms and Immunotherapy.

Baecher-Allan C, Kaskow BJ, Weiner HL.

Neuron. 2018 Feb 21;97(4):742-768. doi: 10.1016/j.neuron.2018.01.021. Review.

Supplemental Content

Loading ...
Support Center